Key terms
About NVO
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest NVO news
Yesterday
12:27pm ET
Novo Nordisk Advances Share Buyback Program
Mar 15
4:47pm ET
Eli Lilly’s (NYSE:LLY) Weight-Loss Drug Outshines Wegovy for First Time
Mar 15
4:55am ET
Piper Sandler healthcare/pharma analysts hold analyst/industry conference call
Mar 14
12:50pm ET
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
Mar 14
11:41am ET
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call
Mar 13
11:00am ET
European Stocks: Unnoticed Records, Overlooked Opportunities
Mar 13
7:26am ET
Corbus Pharmaceuticals price target raised to $58 from $51 at Oppenheimer
Mar 13
5:24am ET
Novo Nordisk downgraded to Neutral from Outperform at Oddo BHF
Mar 12
5:00pm ET
Piper Sandler healthcare/pharma analysts hold analyst/industry conference call
Mar 08
1:48pm ET
Novo Nordisk reports FDA approved label expansion for Wegovy
Mar 08
11:55am ET
Novo Nordisk price target raised to DKK 1,100 from DKK 950 at Deutsche Bank
Mar 08
11:09am ET
Novo Nordisk price target raised to DKK 1,050 from DKK 900 at Barclays
Mar 08
7:04am ET
Novo Nordisk’s (NYSE:NVO) Wegovy Set to Storm China’s Weight Loss Market
Mar 08
6:45am ET
Major Stocks Scale New Highs as Indices Set New Records
Mar 08
6:24am ET
Novo Nordisk surpasses Tesla in valuation, Reuters says
Mar 07
3:34pm ET
Novo results raising the bar for Viking’s oral VK2735, says Oppenheimer
Mar 07
1:49pm ET
William Blair healthcare analysts hold analyst/industry conference call
Mar 07
12:52pm ET
Novo Nordisk (NYSE:NVO) Blasts Up on Weight Loss Drug News
Mar 07
9:40am ET
Unusually active option classes on open March 7th
Mar 07
8:04am ET
Novo Nordisk rallies after amycretin shows 13% weight loss in 12 weeks
Mar 07
7:24am ET
Novo Nordisk providing progress update on ‘Strategic Aspirations 2025’ at CMD
Mar 05
9:44am ET
Novo FLOW trial results positive for Outset Medical, says RBC Capital
Mar 05
7:38am ET
Novo Nordisk’s (NYSE:NVO) Ozempic Shows Promise in Lowering Risk of Kidney Disease Progression
Mar 05
6:19am ET
Eli Lilly works to boost production of weight-loss drug, FT says
Mar 05
6:10am ET
Novo says semaglutide 1.0 mg demonstrates 24% reduction in risk in FLOW trial
Mar 05
5:03am ET
Novo Nordisk reinstated with a Buy at Citi
Mar 04
8:30am ET
WW strategy involves ‘winning at care’, says DA Davidson
Mar 04
5:26am ET
Novo Nordisk upgraded to Buy from Hold at DNB Markets
Mar 01
2:39pm ET
Novo Nordisk price target raised to DKK 930 from DKK 800 at Morgan Stanley
Mar 01
11:05am ET
Novo Nordisk call volume above normal and directionally bullish
Feb 28
3:06pm ET
Novo Nordisk price target raised to DKK 850 from DKK 650 at Berenberg
Mar 17
2:28pm ET
Novo Nordisk Isn't in The "Magnificent Seven," but Here's Why I Think It Should Be
Mar 17
9:46am ET
Novo Nordisk Is Already Working on Wegovy's Successor -- Time to Buy?
Mar 17
9:00am ET
3 Unstoppable Stocks You Can Buy Now Without Any Hesitation
Mar 17
5:50am ET
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?
Mar 17
3:24am ET
Eli Lilly Taps Amazon to Deliver Its Weight Management Blockbuster. Is It Time to Buy the Pharma Stock?
Mar 15
10:15am ET
Novo Nordisk Just Scored a Huge Win. And It's Not Related to Ozempic
Mar 15
7:46am ET
Move Over, Tesla! These 6 Stocks Could Replace It in the "Magnificent 7"
Mar 15
5:50am ET
Should Pfizer Acquire Viking Therapeutics to Take on Eli Lilly and Novo Nordisk in the Obesity Drug Market?
Mar 12
8:31pm ET
Why Novo Nordisk Stock Was a Winner Today
Mar 12
7:45am ET
1 Big New Reason to Buy Novo Nordisk Stock Hand Over Fist Right This Instant
Mar 10
9:29am ET
Forget Tesla: I Think This Stock Should Replace It in the "Magnificent Seven"
Mar 10
4:33am ET
Is Novo Nordisk a Buy After Its New Obesity Candidate's Success in a Clinical Trial?
Mar 07
12:05pm ET
Why Viking Therapeutics Stock Is Plunging Today
Mar 07
11:49am ET
Why Novo Nordisk Stock Is Jumping Today (Hint: It's Not Because of Ozempic or Wegovy)
Mar 06
5:50am ET
Is Viking Therapeutics Stock a Better Buy Than Eli Lilly and Novo Nordisk After the Latest Weight-Loss Drug News?
Mar 05
6:23pm ET
Why Novo Nordisk Stock Tumbled by Nearly 3% on Tuesday
Mar 05
11:16am ET
A New Competitor to Wegovy Could Be on the Way. Should Novo Nordisk Be Worried?
Mar 05
9:53am ET
Prediction: Eli Lilly and Novo Nordisk Stock Could Just be Getting Started. Here's Why
Mar 05
6:15am ET
Better Weight Loss Drug Stock: Viking Therapeutics vs. Eli Lilly
No recent press releases are available for NVO
NVO Financials
Key terms
Ad Feedback
NVO Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
NVO Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range